Home
About
INNA-051
Media Centre
Publications
Contact
Menu Menu

ENA Respiratory begins dosing in phase 2 study of INNA-051 nasal spray

29 January 2026

PharmaTimes

29 January 2026
ENA Respiratory begins dosing in phase 2 study of INNA-051 nasal spray

http://enarespiratory.com/wp-content/uploads/2024/10/Ena_Respiratory_RGB_Color_REV.svg 0 0 Chris F http://enarespiratory.com/wp-content/uploads/2024/10/Ena_Respiratory_RGB_Color_REV.svg Chris F2026-01-29 08:00:292026-03-17 12:29:12ENA Respiratory begins dosing in phase 2 study of INNA-051 nasal spray

Privacy Policy

© ENA Respiratory

Home
About
INNA-051
Media Centre
Publications
Contact

ENA Respiratory Announces Dosing of First Participants in Phase II Study of...Nasal spray could prevent respiratory viruses